Anthony Maurelli - Publications

Affiliations: 
Microbiology Uniformed Services University of the Health Sciences, Bethesda, MD 

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ball LM, Bronstein E, Liechti GW, Maurelli AT. drives into a persistence-like state during co-infection. Infection and Immunity. e0017923. PMID 38014981 DOI: 10.1128/iai.00179-23  0.396
2020 Singh R, Liechti G, Slade JA, Maurelli AT. Oligopeptide Transporter Performs Dual Functions of Oligopeptide Transport and Peptidoglycan Recycling. Infection and Immunity. PMID 32094256 DOI: 10.1128/Iai.00086-20  0.335
2020 Ranjit DK, Liechti GW, Maurelli AT. Chlamydial MreB Directs Cell Division and Peptidoglycan Synthesis in Escherichia coli in the Absence of FtsZ Activity. Mbio. 11. PMID 32071268 DOI: 10.1128/Mbio.03222-19  0.46
2019 Slade JA, Brockett M, Singh R, Liechti GW, Maurelli AT. Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly. Plos Pathogens. 15: e1008078. PMID 31622442 DOI: 10.1371/Journal.Ppat.1008078  0.346
2018 Lampel KA, Formal SB, Maurelli AT. A Brief History of Shigella. Ecosal Plus. 8. PMID 29318984 DOI: 10.1128/ecosalplus.ESP-0006-2017  0.352
2016 Liechti G, Kuru E, Packiam M, Hsu YP, Tekkam S, Hall E, Rittichier JT, VanNieuwenhze M, Brun YV, Maurelli AT. Pathogenic Chlamydia Lack a Classical Sacculus but Synthesize a Narrow, Mid-cell Peptidoglycan Ring, Regulated by MreB, for Cell Division. Plos Pathogens. 12: e1005590. PMID 27144308 DOI: 10.1371/Journal.Ppat.1005590  0.369
2016 Bliven KA, Maurelli AT. Evolution of Bacterial Pathogens Within the Human Host. Microbiology Spectrum. 4. PMID 26999399 DOI: 10.1128/microbiolspec.VMBF-0017-2015  0.343
2015 Packiam M, Weinrick B, Jacobs WR, Maurelli AT. Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly". Proceedings of the National Academy of Sciences of the United States of America. 112: 11660-5. PMID 26290580 DOI: 10.1073/Pnas.1514026112  0.409
2015 Yeruva L, Bowlin AK, Spencer N, Maurelli AT, Rank RG. Chlamydial variants differ in ability to ascend the genital tract in the guinea pig model of chlamydial genital infection. Infection and Immunity. 83: 3176-83. PMID 26015484 DOI: 10.1128/IAI.00532-15  0.392
2015 Fisher DJ, Adams NE, Maurelli AT. Phosphoproteomic Analysis of the Chlamydia caviae Elementary Body and Reticulate Body Forms. Microbiology (Reading, England). PMID 25998263 DOI: 10.1099/mic.0.000116  0.354
2015 Gray MD, Lacher DW, Leonard SR, Abbott J, Zhao S, Lampel KA, Prothery E, Gouali M, Weill FX, Maurelli AT. Prevalence of Shiga toxin-producing Shigella species isolated from French travellers returning from the Caribbean: an emerging pathogen with international implications. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 25980352 DOI: 10.1016/J.Cmi.2015.05.006  0.379
2014 Emanuele AA, Adams NE, Chen YC, Maurelli AT, Garcia GA. Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri. The Journal of Antibiotics. 67: 379-86. PMID 24549153 DOI: 10.1038/ja.2014.10  0.315
2012 Fisher DJ, Fernández RE, Adams NE, Maurelli AT. Uptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT). Plos One. 7: e46052. PMID 23029384 DOI: 10.1371/journal.pone.0046052  0.318
2012 Rank RG, Bowlin AK, Tormanen KI, Wang Y, Maurelli AT. Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis. Infection and Immunity. 80: 612-9. PMID 22144478 DOI: 10.1128/IAI.06054-11  0.417
2010 Faherty CS, Merrell DS, Semino-Mora C, Dubois A, Ramaswamy AV, Maurelli AT. Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition. Bmc Genomics. 11: 272. PMID 20429941 DOI: 10.1186/1471-2164-11-272  0.398
2010 Binet R, Bowlin AK, Maurelli AT, Rank RG. Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. Antimicrobial Agents and Chemotherapy. 54: 1094-101. PMID 20065052 DOI: 10.1128/AAC.01321-09  0.351
2009 Faherty CS, Maurelli AT. Spa15 of Shigella flexneri is secreted through the type III secretion system and prevents staurosporine-induced apoptosis. Infection and Immunity. 77: 5281-90. PMID 19805534 DOI: 10.1128/IAI.00800-09  0.462
2009 Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Molecular Microbiology. 71: 350-68. PMID 19017275 DOI: 10.1111/J.1365-2958.2008.06524.X  0.596
2008 Faherty CS, Maurelli AT. Staying alive: bacterial inhibition of apoptosis during infection. Trends in Microbiology. 16: 173-80. PMID 18353648 DOI: 10.1016/j.tim.2008.02.001  0.381
2008 Zurawski DV, Mumy KL, Badea L, Prentice JA, Hartland EL, McCormick BA, Maurelli AT. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infection and Immunity. 76: 369-79. PMID 17984206 DOI: 10.1128/Iai.00684-07  0.616
2007 Prunier AL, Schuch R, Fernández RE, Mumy KL, Kohler H, McCormick BA, Maurelli AT. nadA and nadB of Shigella flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity. Microbiology (Reading, England). 153: 2363-72. PMID 17600080 DOI: 10.1099/mic.0.2007/006916-0  0.368
2007 Clark CS, Maurelli AT. Shigella flexneri inhibits staurosporine-induced apoptosis in epithelial cells Infection and Immunity. 75: 2531-2539. PMID 17339354 DOI: 10.1128/IAI.01866-06  0.391
2006 Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA, Maurelli AT. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infection and Immunity. 74: 5964-76. PMID 16988276 DOI: 10.1128/Iai.00594-06  0.619
2005 Lario PI, Pfuetzner RA, Frey EA, Creagh L, Haynes C, Maurelli AT, Strynadka NC. Structure and biochemical analysis of a secretin pilot protein. The Embo Journal. 24: 1111-21. PMID 15775974 DOI: 10.1038/Sj.Emboj.7600610  0.335
2004 Honma Y, Fernández RE, Maurelli AT. A DNA adenine methylase mutant of Shigella flexneri shows no significant attenuation of virulence. Microbiology (Reading, England). 150: 1073-8. PMID 15073316 DOI: 10.1099/mic.0.26781-0  0.359
2004 Maurelli AT. Virulence protein export systems in Salmonella and Shigella: a new family or lost relatives? Trends in Cell Biology. 4: 240-2. PMID 14731663 DOI: 10.1016/0962-8924(94)90116-3  0.425
2003 Verma A, Maurelli AT. Identification of two eukaryote-like serine/threonine kinases encoded by Chlamydia trachomatis serovar L2 and characterization of interacting partners of Pkn1. Infection and Immunity. 71: 5772-84. PMID 14500499 DOI: 10.1128/iai.71.10.5772-5784.2003  0.32
2002 Köhler H, Rodrigues SP, Maurelli AT, McCormick BA. Inhibition of Salmonella typhimurium enteropathogenicity by piperidine, a metabolite of the polyamine cadaverine. The Journal of Infectious Diseases. 186: 1122-30. PMID 12355363 DOI: 10.1086/344236  0.463
2002 Kane CD, Schuch R, Day WA, Maurelli AT. MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system. Journal of Bacteriology. 184: 4409-19. PMID 12142411 DOI: 10.1128/jb.184.16.4409-4419.2002  0.553
2001 Schuch R, Maurelli AT. MxiM and MxiJ, base elements of the Mxi-Spa type III secretion system of Shigella, interact with and stabilize the MxiD secretin in the cell envelope. Journal of Bacteriology. 183: 6991-8. PMID 11717255 DOI: 10.1128/JB.183.24.6991-6998.2001  0.388
2001 Schuch R, Maurelli AT. Spa33, a cell surface-associated subunit of the Mxi-Spa type III secretory pathway of Shigella flexneri, regulates Ipa protein traffic. Infection and Immunity. 69: 2180-9. PMID 11254573 DOI: 10.1128/IAI.69.4.2180-2189.2001  0.429
2001 McCormick BA, Fernandez MI, Siber AM, Maurelli AT. Inhibition of Shigella flexneri-induced transepithelial migration of polymorphonuclear leucocytes by cadaverine. Cellular Microbiology. 1: 143-55. PMID 11207548 DOI: 10.1046/j.1462-5822.1999.00014.x  0.402
1999 Schuch R, Maurelli AT. The mxi-Spa type III secretory pathway of Shigella flexneri requires an outer membrane lipoprotein, MxiM, for invasin translocation. Infection and Immunity. 67: 1982-91. PMID 10085046 DOI: 10.1128/IAI.67.4.1982-1991.1999  0.389
1999 Sandlin RC, Maurelli AT. Establishment of unipolar localization of IcsA in Shigella flexneri 2a is not dependent on virulence plasmid determinants. Infection and Immunity. 67: 350-6. PMID 9864236 DOI: 10.1128/IAI.67.1.350-356.1999  0.367
1998 Maurelli AT, Routh PR, Dillman RC, Ficken MD, Weinstock DM, Almond GW, Orndorff PE. Shigella infection as observed in the experimentally inoculated domestic pig, Sus scrofa domestica Microbial Pathogenesis. 25: 189-196. PMID 9817822 DOI: 10.1006/Mpat.1998.0230  0.358
1998 McCormick BA, Siber AM, Maurelli AT. Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium. Infection and Immunity. 66: 4237-43. PMID 9712773 DOI: 10.1128/IAI.66.9.4237-4243.1998  0.433
1998 Maurelli AT, Fernández RE, Bloch CA, Rode CK, Fasano A. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 95: 3943-8. PMID 9520472 DOI: 10.1073/Pnas.95.7.3943  0.322
1995 Sandlin RC, Lampel KA, Keasler SP, Goldberg MB, Stolzer AL, Maurelli AT. Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infection and Immunity. 63: 229-37. PMID 7528731 DOI: 10.1128/iai.63.1.229-237.1995  0.404
1991 Andrews GP, Hromockyj AE, Coker C, Maurelli AT. Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens. Infection and Immunity. 59: 1997-2005. PMID 2037361 DOI: 10.1128/iai.59.6.1997-2005.1991  0.443
1987 Baudry B, Maurelli AT, Clerc P, Sadoff JC, Sansonetti PJ. Localization of plasmid loci necessary for the entry of Shigella flexneri into HeLa cells, and characterization of one locus encoding four immunogenic polypeptides. Journal of General Microbiology. 133: 3403-13. PMID 2846749 DOI: 10.1099/00221287-133-12-3403  0.346
1986 Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infection and Immunity. 51: 461-9. PMID 3510976 DOI: 10.1128/Iai.51.2.461-469.1986  0.469
1985 Maurelli AT, Baudry B, d'Hauteville H, Hale TL, Sansonetti PJ. Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri. Infection and Immunity. 49: 164-171. PMID 2989179 DOI: 10.1128/Iai.49.1.164-171.1985  0.33
1984 Maurelli AT, Blackmon B, Curtiss R. Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid. Infection and Immunity. 43: 397-401. PMID 6360906 DOI: 10.1128/iai.43.1.397-401.1984  0.31
1983 Shaw DR, Maurelli AT, Goguen JD, Straley SC, Curtiss R. Use of UV-irradiated bacteriophage T6 to kill extracellular bacteria in tissue culture infectivity assays Journal of Immunological Methods. 56: 75-83. PMID 6338113 DOI: 10.1016/0022-1759(83)90050-9  0.435
Show low-probability matches.